These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prevention and treatment of osteoporosis: where are we today? Maby JI J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S9-12. PubMed ID: 12625633 [No Abstract] [Full Text] [Related]
9. New developments in osteoporosis treatments. Miller CA Geriatr Nurs; 2000; 21(4):219, 223. PubMed ID: 10945890 [No Abstract] [Full Text] [Related]
10. [Diagnosis and treatment of postmenopausal osteoporosis]. Mizunuma H Nihon Rinsho; 2007 Nov; 65 Suppl 9():490-4. PubMed ID: 18161154 [No Abstract] [Full Text] [Related]
11. [Selective estrogen receptor modulators (SERM's) in postmenopausal women]. Kleiverda G Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2446-7. PubMed ID: 10608980 [No Abstract] [Full Text] [Related]
12. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic therapy for the treatment and prevention of osteoporosis. McClung B; McClung M Nurs Clin North Am; 2001 Sep; 36(3):433-40, viii. PubMed ID: 11532658 [TBL] [Abstract][Full Text] [Related]
14. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front]. MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198 [No Abstract] [Full Text] [Related]
15. Fewer fractures with raloxifene. Feinberg AW Health News; 1999 Oct; 5(12):3. PubMed ID: 10536528 [No Abstract] [Full Text] [Related]
16. Building bone. Depree P Adv Nurse Pract; 2000 Jan; 8(1):36-8. PubMed ID: 11011593 [No Abstract] [Full Text] [Related]
17. Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis? Hathirat S; Evans MF Can Fam Physician; 2001 Oct; 47():1982-4. PubMed ID: 11723592 [No Abstract] [Full Text] [Related]
18. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)? Sambrook P Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191 [TBL] [Abstract][Full Text] [Related]
19. [Raloxifene (Evista) in the treatment of postmenopausal osteoporosis--the profile of the patient]. Kastelan D; Korsić M Reumatizam; 2005; 52(2):67-70. PubMed ID: 16689133 [TBL] [Abstract][Full Text] [Related]